Shopping Cart
Remove All
Your shopping cart is currently empty
Foravirumab (CR4098) is a monoclonal antibody targeting rabies virus glycoprotein (RABV-G) for the study of infectious diseases such as rabies.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | - | In Stock | |
| 5 mg | $589 | - | In Stock | |
| 10 mg | $959 | - | In Stock | |
| 25 mg | $1,420 | - | In Stock | |
| 50 mg | $1,920 | - | In Stock |
| Description | Foravirumab (CR4098) is a monoclonal antibody targeting rabies virus glycoprotein (RABV-G) for the study of infectious diseases such as rabies. |
| In vitro | Foravirumab (CR4098) recognizes a specific epitope located at antigenic site III. Foravirumab binds even to the mutant glycoprotein (N336D) expressed on PER.C6 cells. Foravirumab has a neutralizing potency and broad spectrum similar to CR57 and also neutralizes escape mutants of CR57. [1] |
| In vivo | Foravirumab (10, 20, and 40 IU/kg) was effective in preventing fatal rabies virus infection in Syrian hamsters infected with natural rabies virus. [1] |
| Synonyms | CR4098, CR 4098, CL-184, CL184 |
| Cas No. | 944548-38-3 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.